Fundraising Fox

Metri Bio

3 known investors

Metri is a biotech company developing first-in-class, disease-modifying therapeutics for endometriosis and other uterine diseases originating in the endometrium. It is building a platform to identify reliable disease targets for conditions that currently lack targeted treatments.

BiotechFemTechHealthtech

Founders & leadership

AA
Ashley AbelCofounder30 Under 30 2026
AAAshley Abel, Ph.D.
Ashley Abel, Ph.D.inFounderFounder at First-in-class therapeutics for endometriosis

Investors · 3

Fifty YearsSan Francisco · $250K – $2M
Pace VenturesBerlin · $550K – $1.6Mvia Marius Swart · inferred
Pillar VCBoston · $50K – $4M

Frequently asked questions

What does Metri Bio do?
Metri is a biotech company developing first-in-class, disease-modifying therapeutics for endometriosis and other uterine diseases originating in the endometrium. It is building a platform to identify reliable disease targets for conditions that currently lack targeted treatments.
Who founded Metri Bio?
Metri Bio was founded by Ashley Abel, Ashley Abel, Ph.D..
Who are Metri Bio's investors?
Metri Bio's investors include Fifty Years, Pace Ventures, Pillar VC.